Cite
HARVARD Citation
Lim, R. et al. (2021). The noradrenergic agent reboxetine plus the antimuscarinic hyoscine butylbromide reduces sleep apnoea severity: a double‐blind, placebo‐controlled, randomised crossover trial. Journal of physiology. pp. 4183-4195. [Online].